Invesco S&P MidCap Quality (XMHQ)
XMHQ price chart
XMHQ fund facts
Returns and risk
Cost: expense ratio
On $10,000 invested that is about $25 a year in fund costs, taken out of the fund's assets. The prospectus shows 0.31% before fee waivers.
Income: distributions
XMHQ top holdings
| # | Holding | Weight |
|---|---|---|
| 1 | Invesco Private Prime Fund | 7.61% |
| 2 | Illumina, Inc. ILMN | 4.21% |
| 3 | TechnipFMC PLC | 4.14% |
| 4 | Everpure Inc. P | 3.28% |
| 5 | Curtiss-Wright Corp. | 3.21% |
| 6 | Medpace Holdings, Inc. | 3.13% |
| 7 | Invesco Private Government Fund | 2.93% |
| 8 | nVent Electric PLC | 2.93% |
| 9 | Manhattan Associates, Inc. | 2.79% |
| 10 | Exelixis, Inc. | 2.70% |
Similar Mid-cap ETFs
TMSL T. Rowe Price Small-Mid Cap0.55% fee · +18.2% 1y CGMM Capital Group U.S. Small and M...0.51% fee · +11.2% 1y IJK iShares S&P Mid-Cap 400 Growth0.17% fee · +14.0% 1y FMDE Fidelity Enhanced Mid Cap0.23% fee · +17.5% 1y FFSM Fidelity Fundamental Small-Mid...0.43% fee · +16.3% 1y IJJ iShares S&P Mid-Cap 400 Value0.18% fee · +13.6% 1y All mid-cap ETFs →XMHQ: frequently asked questions
What is XMHQ?
XMHQ is the Invesco S&P MidCap Quality ETF, issued by Invesco, listed on NYSE ARCA. By our rules it is classed as "Mid-cap". Its latest SEC filing lists 83 holdings.
What is the expense ratio of XMHQ?
XMHQ charges 0.25% a year after fee waivers (gross 0.31%), according to its prospectus filed with the SEC on 27 Aug 2025. On $10,000 that is about $25 a year in fund costs.
Does XMHQ pay dividends?
Yes. XMHQ paid 0.66 per share over the last 12 months, quarterly, a trailing yield of 0.57% on today's price. The latest ex-dividend date was 21 Sep 2026.
What does XMHQ hold?
The largest holdings in the latest SEC filing are Invesco Private Prime Fund (7.6%), Illumina, Inc. (4.2%), TechnipFMC PLC (4.1%). The top 10 together make up 36.9% of the fund.
How has XMHQ performed?
Total return including distributions to 22 Oct 2026: 1 year +13.1%, 3 years +17.0% a year, 5 years +9.6% a year. Past performance does not guarantee future results.
Where the numbers come from
StocksXray is for education only and is not financial advice or a recommendation to buy or sell anything. Past performance does not guarantee future results; funds can lose value.